NO20063963L - Multipartikulaere 0-desmetylvenlafaksinsalter og anvendelser derav - Google Patents
Multipartikulaere 0-desmetylvenlafaksinsalter og anvendelser deravInfo
- Publication number
- NO20063963L NO20063963L NO20063963A NO20063963A NO20063963L NO 20063963 L NO20063963 L NO 20063963L NO 20063963 A NO20063963 A NO 20063963A NO 20063963 A NO20063963 A NO 20063963A NO 20063963 L NO20063963 L NO 20063963L
- Authority
- NO
- Norway
- Prior art keywords
- multiparticular
- desmethylvenlafaxine salts
- desmethylvenlafaxine
- salts
- odv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54238404P | 2004-02-06 | 2004-02-06 | |
PCT/US2005/002215 WO2005077340A1 (en) | 2004-02-06 | 2005-01-25 | Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20063963L true NO20063963L (no) | 2006-09-05 |
Family
ID=34860300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063963A NO20063963L (no) | 2004-02-06 | 2006-09-05 | Multipartikulaere 0-desmetylvenlafaksinsalter og anvendelser derav |
Country Status (21)
Country | Link |
---|---|
US (1) | US20050175698A1 (ru) |
EP (2) | EP1711167A1 (ru) |
JP (1) | JP2007520553A (ru) |
KR (1) | KR20060132891A (ru) |
CN (1) | CN1917860A (ru) |
AR (1) | AR050230A1 (ru) |
AU (1) | AU2005212166A1 (ru) |
BR (1) | BRPI0507372A (ru) |
CA (1) | CA2554559A1 (ru) |
CR (1) | CR8535A (ru) |
EC (1) | ECSP066827A (ru) |
IL (1) | IL177052A0 (ru) |
NO (1) | NO20063963L (ru) |
PA (1) | PA8622601A1 (ru) |
PE (1) | PE20050771A1 (ru) |
RU (1) | RU2006127437A (ru) |
SG (1) | SG149894A1 (ru) |
SV (1) | SV2005002008A (ru) |
TW (1) | TW200528092A (ru) |
WO (1) | WO2005077340A1 (ru) |
ZA (1) | ZA200606526B (ru) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
PL350924A1 (en) * | 1999-04-06 | 2003-02-10 | Sepracor Inc | Derivatives of venlafaxine and methods of preparing and using the same |
ES2290281T5 (es) | 2001-02-12 | 2017-09-11 | Wyeth Llc | Sal de succinato de O-desmetil-venlafaxina |
AU2005320672B2 (en) * | 2004-12-27 | 2011-01-06 | Astellas Pharma Inc. | Stable particulate pharmaceutical composition of solifenacin or salt thereof |
JP2008534592A (ja) * | 2005-03-31 | 2008-08-28 | ワイス | O−デスメチルベンラファキシンおよびバゼドキシフェンの組み合わせ生成物およびその使用 |
EP1904046A4 (en) * | 2005-07-06 | 2008-10-01 | Sepracor Inc | COMBINATIONS OF ESZOPICLON AND O-DESMETHYLVENLAFAXINE AND METHOD FOR THE TREATMENT OF MENOPAUSE AND HUMOR FLUCTUATIONS; ANXIETY AND COGNITIVE INTERFERENCE |
WO2007011619A2 (en) * | 2005-07-15 | 2007-01-25 | Wyeth | Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate |
US7595340B2 (en) * | 2005-07-15 | 2009-09-29 | Wyeth | Serotonin and norepinephrine reuptake inhibitor and uses thereof |
CN101223129A (zh) * | 2005-07-15 | 2008-07-16 | 惠氏公司 | 高度选择性血清素和去甲肾上腺素双重再摄取抑制剂和其用途 |
US7687520B2 (en) * | 2005-07-15 | 2010-03-30 | Wyeth Llc | Serotonin and norepinephrine reuptake inhibitors and uses thereof |
TW200806282A (en) * | 2006-05-05 | 2008-02-01 | Wyeth Corp | Solid dosage formulations |
EP1870395A1 (en) | 2006-06-19 | 2007-12-26 | KRKA, D.D., Novo Mesto | Process for preparation of o-desmethylvenlafaxine and its analogue |
WO2009009665A2 (en) * | 2007-07-12 | 2009-01-15 | Dr. Reddy's Laboratories, Ltd. | O-desmethylvenlafaxine |
US20100330172A1 (en) * | 2007-10-16 | 2010-12-30 | Alphapharm Pty Ltd | Controlled-release pharmaceutical formulation |
WO2009053840A2 (en) * | 2007-10-22 | 2009-04-30 | Actavis Group Ptc Ehf | Solid forms of (±)-o-desmethylvenlafaxine salts |
WO2011121475A2 (en) | 2010-03-31 | 2011-10-06 | Wockhardt Limited | Modified release dosage form comprising desvenlafaxine or salts thereof |
WO2012140577A1 (en) | 2011-04-12 | 2012-10-18 | Lupin Limited | Modified release pharmaceutical compositions of desvenlafaxine |
MX2014013326A (es) * | 2012-05-03 | 2015-08-10 | Cipla Ltd | Composición antirretroviral. |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3081496A (en) * | 1959-10-15 | 1963-03-19 | John F Moore | Method of forming flexible sheets of cured foamed rubber |
AT294000B (de) * | 1965-01-11 | 1971-11-10 | Diersch & Schroeder | Verfahren zur Herstellung von Teppichen oder Läufern |
US3885257A (en) * | 1972-10-30 | 1975-05-27 | Evans Ronald J P | Pressure controlled resilient supporting structure |
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US4603445A (en) * | 1983-09-09 | 1986-08-05 | Span-America Medical Systems, Inc. | Support pad and method of manufacture |
US5099627A (en) * | 1990-09-28 | 1992-03-31 | Benjamin Obdyke Incorporated | Ventilated roof construction and method |
US5203703A (en) * | 1991-08-27 | 1993-04-20 | Schneiderman Marc J | Deglutition training method and apparatus |
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
US6162309A (en) * | 1998-04-21 | 2000-12-19 | Burlington Industries, Inc. | Reinforced foam backed carpet |
US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
US6197828B1 (en) * | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
PL350924A1 (en) * | 1999-04-06 | 2003-02-10 | Sepracor Inc | Derivatives of venlafaxine and methods of preparing and using the same |
AU5738700A (en) * | 1999-06-15 | 2001-01-02 | American Home Products Corporation | Enantiomers of o-desmethyl venlafaxine |
US6863972B2 (en) * | 2001-01-09 | 2005-03-08 | Crane Plastics Company Llc | Synthetic wood component having a foamed polymer backing |
ES2290281T5 (es) | 2001-02-12 | 2017-09-11 | Wyeth Llc | Sal de succinato de O-desmetil-venlafaxina |
US20030152741A1 (en) * | 2002-02-05 | 2003-08-14 | Robbins Jeffrey L. | Patterned polyurethane foam and a process for the production of tufted goods with patterned foam backing |
WO2003082806A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon B.V. | Venlafaxine base |
NZ537142A (en) * | 2002-06-10 | 2008-01-31 | Wyeth Corp | Novel formate salt of O-desmethyl-venlafaxine |
JP2004359665A (ja) * | 2003-05-30 | 2004-12-24 | Rohm & Haas Co | 生体利用性増強剤を含有する治療組成物 |
-
2005
- 2005-01-25 JP JP2006552145A patent/JP2007520553A/ja not_active Withdrawn
- 2005-01-25 RU RU2006127437/15A patent/RU2006127437A/ru not_active Application Discontinuation
- 2005-01-25 AU AU2005212166A patent/AU2005212166A1/en not_active Abandoned
- 2005-01-25 SG SG200900798-0A patent/SG149894A1/en unknown
- 2005-01-25 KR KR1020067015668A patent/KR20060132891A/ko not_active Application Discontinuation
- 2005-01-25 BR BRPI0507372-3A patent/BRPI0507372A/pt not_active IP Right Cessation
- 2005-01-25 EP EP05711931A patent/EP1711167A1/en not_active Withdrawn
- 2005-01-25 US US11/042,436 patent/US20050175698A1/en not_active Abandoned
- 2005-01-25 CN CNA2005800042516A patent/CN1917860A/zh active Pending
- 2005-01-25 AR ARP050100248A patent/AR050230A1/es unknown
- 2005-01-25 EP EP09002123A patent/EP2052717A1/en not_active Withdrawn
- 2005-01-25 WO PCT/US2005/002215 patent/WO2005077340A1/en active Application Filing
- 2005-01-25 CA CA002554559A patent/CA2554559A1/en not_active Abandoned
- 2005-01-27 TW TW094102533A patent/TW200528092A/zh unknown
- 2005-01-31 PE PE2005000114A patent/PE20050771A1/es not_active Application Discontinuation
- 2005-02-03 PA PA20058622601A patent/PA8622601A1/es unknown
- 2005-02-04 SV SV2005002008A patent/SV2005002008A/es not_active Application Discontinuation
-
2006
- 2006-07-24 IL IL177052A patent/IL177052A0/en unknown
- 2006-07-25 CR CR8535A patent/CR8535A/es not_active Application Discontinuation
- 2006-08-04 ZA ZA200606526A patent/ZA200606526B/xx unknown
- 2006-09-05 NO NO20063963A patent/NO20063963L/no not_active Application Discontinuation
- 2006-09-06 EC EC2006006827A patent/ECSP066827A/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW200528092A (en) | 2005-09-01 |
PE20050771A1 (es) | 2005-11-15 |
PA8622601A1 (es) | 2005-10-28 |
RU2006127437A (ru) | 2008-03-20 |
ECSP066827A (es) | 2006-11-24 |
US20050175698A1 (en) | 2005-08-11 |
SV2005002008A (es) | 2005-11-04 |
EP1711167A1 (en) | 2006-10-18 |
IL177052A0 (en) | 2006-12-10 |
BRPI0507372A (pt) | 2007-07-10 |
AU2005212166A1 (en) | 2005-08-25 |
SG149894A1 (en) | 2009-02-27 |
CA2554559A1 (en) | 2005-08-25 |
ZA200606526B (en) | 2010-03-31 |
JP2007520553A (ja) | 2007-07-26 |
EP2052717A1 (en) | 2009-04-29 |
WO2005077340A1 (en) | 2005-08-25 |
CN1917860A (zh) | 2007-02-21 |
CR8535A (es) | 2006-12-07 |
AR050230A1 (es) | 2006-10-11 |
KR20060132891A (ko) | 2006-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063963L (no) | Multipartikulaere 0-desmetylvenlafaksinsalter og anvendelser derav | |
NL301145I2 (nl) | Tirbanibulin | |
HK1101890A1 (en) | Systems and methods for ex-vivo organ care | |
NO20082305L (no) | Mikrobiologisk stabilisert ol | |
CY1117721T1 (el) | Κυτταρα προελευσης αμνιακου υγρου | |
ATE474617T1 (de) | Medizinproduktsysteme | |
NO20054369L (no) | Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse | |
TW200738270A (en) | Method of treating depression using a TNFα antibody | |
TW200608961A (en) | Methods and reagents for the treatment of metabolic disorders | |
NO20081042L (no) | PPAR aktive forbindelser | |
TW200722897A (en) | Projection partitioning and aligning | |
NO20082082L (no) | Modulatorer for ATP-bindingskassettstransportere | |
MX2019005150A (es) | Inhibidores de la tirosina-cinasa de bruton. | |
WO2006111961A3 (en) | Methods and devices for limiting gastric expansion | |
NO20083670L (no) | Forbindelser og fremgangsmater for modulering av proteinomsetning | |
WO2007021989A3 (en) | Interlayers comprising an ultraviolet curable layer | |
MX2007005202A (es) | Polisacaridos de estreptococo modificados y usos de los mismos. | |
MX2010001657A (es) | Reguladores de mmp-9 y usos de los mismos. | |
DE602005015102D1 (de) | Wässrige dispersionen von silikon-polyether-blockcopolymeren | |
WO2005044199A3 (en) | Combination of proton pump inhibitor and sleep aid | |
BRPI0416268A (pt) | composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla | |
DK1560812T3 (da) | Aminocyclohexyletherforbindelser og anvendelser deraf | |
NO20064715L (no) | Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C) | |
NO20050962D0 (no) | Fremgangsmate, system og kilde for implementering av flerbruker oppkobling | |
DE502004005907D1 (de) | Selbstemulgierende wässrige polyurethandispersionen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |